Clinical Trial Update: Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD [NA]

View source ↗

Summary

A completed clinical trial evaluating the short- and long-term effects of ranibizumab on retinal function in wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: University of Luebeck | Conditions: Age-Related Macular Degeneration, Retinal Function | NA | Status: COMPLETED